Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.

UMIN ID: UMIN000000732

Registered date:10/06/2007

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Kidney transplantation
• Date of first enrollment: 2006/06/01
• Target sample size: 70
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): cyclosporinbasiliximab + steroids + mizoribine

Outcome(s)

• Primary Outcome: Incidence of virus infection
• Secondary Outcome: Rejection reactions (incidence, types, severity), patient survival rate, graft suvival rate, incidence of adverse events / abnormalities in the laboratory values.

Key inclusion & exclusion criteria

• Age minimum: 2years-old
• Age maximum: 70years-old
• Gender: Male and Female
• Exclude criteria: 1.The patient who has a history of hypersensitivity against components of either one of the following drugs: Bredinin tablet, Neoral or Simulect. 2.The patient who is pregnant or a female patient who is expecting to become pregnant. 3.The patients who showed a positive result with cross match test. 4.The patient who recived ABO incompatible donor. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.

Related Information

• Primary Sponsor: MNKT Forum
• Source(s) of Monetary Support: Self funding